Sentence examples for assay their potential from inspiring English sources

To assay their potential to differentiate into adipocytes, cells were cultured for 3 weeks in three different conditions: AD for the whole period (AD cultures); AD supplemented for the whole period with 25 ng/ml FasL (AD/FasL cultures), which inhibited adipogenesis; and AD/FasL for the first 2 weeks, and then AD without FasL in the final week (AD/FasL/-FasL cultures).

To investigate whether the effect of ponatinib was caused by a target shared with the other BCR-ABL inhibitors, we assayed their potential to block necroptosis and their toxicity.

Here, we functionally dissected the individual components of mir-17-92 mir-17-92 mir-17-92umorigenic potential in vivo.

Three series of homologous dendritic amphiphiles RCONHC CH2CH2COOH 3, 1(n); ROCONHC CH2CH2COOH 3, 2(n); RNHCONHC CH2CH2COOH 3, 3(n), where R = n-CnH2n+1 and n = 13 22 carbon atoms were assayed for their potential to serve as antimicrobial components in a topical vaginal formulation.

Various analogs of flavins, 5-deazaflavins, and flavin-5-oxides were docked into the binding site of protein tyrosine kinase pp60c-src, and some of them were assayed for their potential antitumor and PKC (protein kinase C) inhibitory activities in vitro.

MSCs readily formed extensive networks in Matrigel™ and CAM assays, highlighting their potential to contribute to blood-vessel formation.

In the present review we discuss in detail the major diagnostic tests available such as MammaPrint dx, Oncotype dx, PAM50, Mammostrat, IHC4, MapQuant DX, Theros-Breast Cancer Gene Expression Ratio Assay, and their potential clinical applications.

Based on structural similarities, docked positions, protein-ligand interactions, and the limitations of commercial availability, two groups of structures (Figure 3) distinguished themselves for use in the in vivo plaque formation assay for their potential inhibitory effects on DV propagation in cultured cells.

Variants of this foldamer are active in an antithrombin III factor Xa assay, showing their potential as heparin reversal agents.

Although these results are not yet publicly available, the July 2002 Statement by the U.S. Department of Health and Human Services regarding hand-held assays for identification of Bacillus anthracis spores stated, "These studies confirm the low sensitivity of such assays and their potential to produce false-positive results with non-anthrax bacteria and chemicals.

In this Account, we summarize the continuous development of these NanoVelcro CTC assays and their potential applications in oncology clinics.